Arama Sonuçları - C. Frank Bennett

Sonuçları Daraltın
  1. 1
    Therapeutic Antisense Oligonucleotides Are Coming of Age

    Therapeutic Antisense Oligonucleotides Are Coming of Age Yazar: C. Frank Bennett

    Baskı/Yayın Bilgisi 2019
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  2. 2
    Purification and characterization of a phosphoinositide-specific phospholipase C from guinea pig uterus. Phosphorylation by protein kinase C in vivo.

    Purification and characterization of a phosphoinositide-specific phospholipase C from guinea pig uterus. Phosphorylation by protein kinase C in vivo. Yazar: C. Frank Bennett, Stanley T. Crooke

    Baskı/Yayın Bilgisi 1987
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  3. 3
    Selective tissue targeting of synthetic nucleic acid drugs

    Selective tissue targeting of synthetic nucleic acid drugs Yazar: Punit P. Seth, Michael Tanowitz, C. Frank Bennett

    Baskı/Yayın Bilgisi 2019
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  4. 4
    Antisense Drugs Make Sense for Neurological Diseases

    Antisense Drugs Make Sense for Neurological Diseases Yazar: C. Frank Bennett, Holly Kordasiewicz, Don W. Cleveland

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  5. 5
    RNase H-mediated degradation of toxic RNA in myotonic dystrophy type 1

    RNase H-mediated degradation of toxic RNA in myotonic dystrophy type 1 Yazar: Johanna E. Lee, C. Frank Bennett, Thomas A. Cooper

    Baskı/Yayın Bilgisi 2012
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  6. 6
    Nonhistone protein BA is a glutathione S-transferase localized to interchromatinic regions of the cell nucleus.

    Nonhistone protein BA is a glutathione S-transferase localized to interchromatinic regions of the cell nucleus. Yazar: C. Frank Bennett, D. L. Spector, Lynn C. Yeoman

    Baskı/Yayın Bilgisi 1986
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  7. 7
    Antisense Oligonucleotide Therapies for Neurodegenerative Diseases

    Antisense Oligonucleotide Therapies for Neurodegenerative Diseases Yazar: C. Frank Bennett, Adrian R. Krainer, Don W. Cleveland

    Baskı/Yayın Bilgisi 2019
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  8. 8
    Blocking of heart allograft rejection by intercellular adhesion molecule-1 antisense oligonucleotides alone or in combination with other immunosuppressive modalities.

    Blocking of heart allograft rejection by intercellular adhesion molecule-1 antisense oligonucleotides alone or in combination with other immunosuppressive modalities. Yazar: S M Stepkowski, Yan Tu, Thomas P. Condon, C. Frank Bennett

    Baskı/Yayın Bilgisi 1994
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  9. 9
    Antisense-based therapy for the treatment of spinal muscular atrophy

    Antisense-based therapy for the treatment of spinal muscular atrophy Yazar: Frank Rigo, Yimin Hua, Adrian R. Krainer, C. Frank Bennett

    Baskı/Yayın Bilgisi 2012
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  10. 10
    The Role of Antiapoptotic Bcl-2 Family Members in Endothelial Apoptosis Elucidated with Antisense Oligonucleotides

    The Role of Antiapoptotic Bcl-2 Family Members in Endothelial Apoptosis Elucidated with Antisense Oligonucleotides Yazar: Elizabeth J. Ackermann, Jennifer K. Taylor, Ranjit Narayana, C. Frank Bennett

    Baskı/Yayın Bilgisi 1999
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  11. 11
    Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides

    Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides Yazar: Richard S. Geary, Daniel A. Norris, Rosie Z. Yu, C. Frank Bennett

    Baskı/Yayın Bilgisi 2015
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  12. 12
    RNA-Targeted Therapeutics

    RNA-Targeted Therapeutics Yazar: Stanley T. Crooke, Joseph L. Witztum, C. Frank Bennett, Brenda F. Baker

    Baskı/Yayın Bilgisi 2018
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  13. 13
    RNA-Targeted Therapeutics

    RNA-Targeted Therapeutics Yazar: Stanley T. Crooke, Joseph L. Witztum, C. Frank Bennett, Brenda F. Baker

    Baskı/Yayın Bilgisi 2019
    Tam Metin Erişim Tam Metin Erişim
    Errata/Corrigenda
    Favorilerime ekle
    Kaydedildi:
  14. 14
    Nonsense-mediated decay as a terminating mechanism for antisense oligonucleotides

    Nonsense-mediated decay as a terminating mechanism for antisense oligonucleotides Yazar: Amanda J. Ward, Michaela Norrbom, Seung Chun, C. Frank Bennett, Frank Rigo

    Baskı/Yayın Bilgisi 2014
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  15. 15
    Comparison of the efficacy of MOE and PMO modifications of systemic antisense oligonucleotides in a severe SMA mouse model

    Comparison of the efficacy of MOE and PMO modifications of systemic antisense oligonucleotides in a severe SMA mouse model Yazar: Lei Sheng, Frank Rigo, C. Frank Bennett, Adrian R. Krainer, Yimin Hua

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  16. 16
    Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters.

    Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol e... Yazar: Nicholas M. Dean, Robert A. McKay, Thomas P. Condon, C. Frank Bennett

    Baskı/Yayın Bilgisi 1994
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  17. 17
    Manipulation of PK-M mutually exclusive alternative splicing by antisense oligonucleotides

    Manipulation of PK-M mutually exclusive alternative splicing by antisense oligonucleotides Yazar: Zhenxun Wang, Hyun Yong Jeon, Frank Rigo, C. Frank Bennett, Adrian R. Krainer

    Baskı/Yayın Bilgisi 2012
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  18. 18
    Enhancement of SMN2 Exon 7 Inclusion by Antisense Oligonucleotides Targeting the Exon

    Enhancement of SMN2 Exon 7 Inclusion by Antisense Oligonucleotides Targeting the Exon Yazar: Yimin Hua, Timothy A. Vickers, Brenda F. Baker, C. Frank Bennett, Adrian R. Krainer

    Baskı/Yayın Bilgisi 2007
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  19. 19
    Widespread recognition of 5′ splice sites by noncanonical base-pairing to U1 snRNA involving bulged nucleotides

    Widespread recognition of 5′ splice sites by noncanonical base-pairing to U1 snRNA involving bulged nucleotides Yazar: Xavier Roca, Martin Akerman, Hans Gaus, Andrés Berdeja, C. Frank Bennett, Adrian R. Krainer

    Baskı/Yayın Bilgisi 2012
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  20. 20
    Antisense Masking of an hnRNP A1/A2 Intronic Splicing Silencer Corrects SMN2 Splicing in Transgenic Mice

    Antisense Masking of an hnRNP A1/A2 Intronic Splicing Silencer Corrects SMN2 Splicing in Transgenic Mice Yazar: Yimin Hua, Timothy A. Vickers, Hazeem L. Okunola, C. Frank Bennett, Adrian R. Krainer

    Baskı/Yayın Bilgisi 2008
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:

Arama Araçları: